Skip to main content
AmigoFish

Prenuvo CEO on Full-Body MRIs and the Future of Healthcare

From McKinsey & Company · · 21 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.

If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.

Watch on YouTube

Not rated yet

Description

A full-body MRI took about an hour. Then came the call: “We found something. It seems serious.” For McKinsey Senior Partner Seth Goldstrom, it was a stage 1A kidney tumor, caught early and removed.

In episode of _Winning,_ Goldstrom and McKinsey Senior Partner Kevin Carmody speak with Andrew Lacy, founder and CEO of Prenuvo, about why he believes he saw the future of healthcare, what a failed pricing experiment taught him about psychology, and how Prenuvo is trying to turn a one-time scan into a lasting health partnership.

*Chapters:* 00:00 – How a full-body MRI detected an early-stage tumor 01:28 – "I’d seen the future of healthcare" 03:44 – Prenuvo’s vision for preventive healthcare 05:34 – Reward the experiment, not just the outcome 12:29 – Turning a one-time scan into a lifelong partnership 13:41 – Converting skeptical doctors and building a team of pioneers 17:28 – A 40-year-old spine at 25? What AI revealed 19:31 – Andrew Lacey’s biggest leadership lesson

Read the transcript: https://www.mckinsey.com/featured-insights/prenuvos-andrew-lacy-on-making-healthcare-proactive

Subscribe to our channel: http://mck.co/YouTube Subscribe to our newsletters: http://mck.co/Subscribe

*Find us on:* Facebook: http://mck.co/Facebook Twitter: http://mck.co/Twitter LinkedIn: http://mck.co/LinkedIn Instagram: http://mck.co/Instagram

See www.mckinsey.com/privacy-policy for privacy information.

_Comments and opinions expressed by interviewees are their own and do not represent or reflect the opinions, policies, or positions of McKinsey & Company or have its endorsement._

Back to McKinsey & Company · Report a problem